Multiple Sclerosis
IMMUNOLOGICA offers a therapy developed by the School of Pharmacy of the University of Nottingham to reduce the progression of multiple sclerosis. This is an experimental therapy which is in the process of being approved as medical treatment. Since it has not been approved yet, we can offer it as an alternative therapy and not as a medical treatment.
The current development is being sudsidised by the Multiple Sclerosis Society and it is foreseen that the treatment will be approved in a couple of years.
Therapy consists in the use of the immuno-regulatory properties of one type of intestinal nematode helminth (intestinal parasite). Basically, the incidence of autoimmune diseases (multiple sclerosis among them) is inversely proportional to the presence of intestinal parasites worldwide. This has prompted researchers from top centres worldwide to investigate the therapeutic use of these nematodes.
Below you will find graphs of the expected results according to the studies carried out by immuno-neurologist Jorge Correale. The result of this study is extremely encouraging, even though it is the only one on human beings and even though it has been carried out with individuals with natural, non-therapeutic, parasitism.
And results in the progression of magnetic resonances.
Studies in humans are accompanied by animal and epidemiological studies that confirm the effectiveness of the use of helminths for the control of multiple sclerosis. Autoimmune diseases affect approximately 8% of the adult population in Europe and North America. Among these we can find multiple sclerosis, an inflammatory, demyelinating disease that affects the central nervous system and whose abnormal immune mechanism causes lesions in the myelin.
Multiple sclerosis is currently considered to be the prototypical example of organ-specific autoimmunity regulated by Th1 Lymphocytes, with both genetic and environmental factors as triggers for the disease.
Multiple sclerosis has steadily increased in the first world since the end of the XXth century. In contrast, its frequency is relatively low in less developed countries.
In medicine, the hygiene hypothesis states that lack of exposure to infectious agents, symbiotic organisms (like intestinal flora) and parasites in early childhood increases the possibility of developing allergies and autoimmune diseases. The hygiene hypothesis tries to explain why allergies, asthma and other autoimmune diseases have grown so much in developed countries while they are so rare in third-world countries.
Intestinal parasitisms in humans were almost universal until the beginning of the XXth century. However, they have become rare in industrialised nations as a result of all the campaigns for the erradication of helminths at the end of the century and as people adopted more hygienic lifestyles. However, more than a billion people still have these infectious agents in developing countries, where multiple sclerosis is rare.
Helminths survive by using a mechanism of regulation of the behaviour of the human immunological system. They use different immuno-regulatory molecules that alter human immunological responses. Research of helminths for treating autoimmune diseases is growing.
The following table shows that the relation between multiple sclerosis and parasite infections is inversely proportional. (Source: University of Wisconsin Medical School, USA). We can see the relation is inversely proportional. Note: This table focusses on one type of helminth only.
Multiple Sclerosis Vs Trichuris trichiura
Several studies on mice have shown the effectiveness of inoculating mice with parasites to minimise the effects of encephalomyelitis. See graph of one of these studies.
Severity of encephalomyelitis on mice with and without parasites
The studies carried out by Doctor Correale showed that the progression of lesions and the progression of Multiple Sclerosis was much slower (practically non-existent) in patients that carried helminths in their intestines than in those patients who did not.
These, and other, studies of multiple sclerosis and other autoimmune diseases have given birth to helmithic therapy as a way of reducing and stopping the progression of these diseases.
IMMUNOLOGICA provides people who suffer from Multiple Sclerosis with this therapy, which generates great expectations of improvement in the progression of the disease.
If you wish to learn more about how heminthic therapy can help you with multiple sclerosis, contact us.
—————————————————————————————————————————————————————
OTHER LENGUAGES, Otros idiomas: To see this information in English: multiple sclerosis. Um zu sehen, diese Informationen in deutscher Sprache: multiple sklerose. En Español Esclerosis múltiple. Dans ce frances informations de l’expéditeur Sclérose en plaques.
—————————————————————————————————————————————————————